Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2015).
Articles in this Issue were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence.
Articles are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Sci. Pharm. 2009, 77(Short Lectures (SL)), 191; https://doi.org/10.3797/scipharm.oephg.21.SL-24 (registering DOI)
Gadolinium-labeled PLGA Nanoparticles for Magnetic Resonance Imaging
Department of Pharmaceutical Technology and Biopharmaceutics, University of Vienna, Althanstraße 14, A-1090, Vienna, Austria
Biomedical NMR, Department of Biomedical Engineering, Eindhoven University of Technology, PO Box 513, 5600 MB, Eindhoven, The Netherlands
Department of Environmental Geosciences, University of Vienna, Althanstraße 14, A-1090, Vienna, Austria
Author to whom correspondence should be addressed.
Received: 16 April 2009 / Accepted: 16 April 2009 / Published: 16 April 2009
Abstract To date, the main two classes of clinically used contrast agents for magnetic resonance imaging (MRI) are soluble paramagnetic gadolinium chelates and superparamagnetic iron oxide particles. While iron oxides predominantly increase T2-relaxivity and thus provide negative contrast, gadolinium chelates are often requested as they increase T1-relaxivity and enhance positive contrast. As particulate contrast agents are preferable due to a more favorable signal-to-noise ratio, the goal of our present work was the development of poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles labeled with chelated gadolinium.
This is an open access article distributed under the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
Share & Cite This Article
MDPI and ACS Style
RATZINGER, G.; AGRAWAL, P.; WIRTH, M.; KÖRNER, W.; NICOLAY, K.; GABOR, F. Gadolinium-labeled PLGA Nanoparticles for Magnetic Resonance Imaging. Sci. Pharm. 2009, 77, 191.
RATZINGER G, AGRAWAL P, WIRTH M, KÖRNER W, NICOLAY K, GABOR F. Gadolinium-labeled PLGA Nanoparticles for Magnetic Resonance Imaging. Scientia Pharmaceutica. 2009; 77(Short Lectures (SL)):191.
RATZINGER, G.; AGRAWAL, P.; WIRTH, M.; KÖRNER, W.; NICOLAY, K.; GABOR, F. 2009. "Gadolinium-labeled PLGA Nanoparticles for Magnetic Resonance Imaging." Sci. Pharm. 77, Short Lectures (SL): 191.
Show more citation formats
Show less citations formats
[Return to top]
For more information on the journal statistics, click here
Multiple requests from the same IP address are counted as one view.